Literature DB >> 9003781

The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.

M Kitagawa1, H Higashi, H K Jung, I Suzuki-Takahashi, M Ikeda, K Tamai, J Kato, K Segawa, E Yoshida, S Nishimura, Y Taya.   

Abstract

Cyclin D-Cdk4/6 and cyclin A/E-Cdk2 are suggested to be involved in phosphorylation of the retinoblastoma protein (pRB) during the G1/S transition of the cell cycle. However, it is unclear why several Cdks are needed and how they are different from one another. We found that the consensus amino acid sequence for phosphorylation by cyclin D1-Cdk4 is different from S/T-P-X-K/R, which is the consensus sequence for phosphorylation by cyclin A/E-Cdk2 using various synthetic peptides as substrates. Cyclin D1-Cdk4 efficiently phosphorylated the G1 peptide, RPPTLS780PIPHIPR that contained a part of the sequence of pRB, while cyclins E-Cdk2 and A-Cdk2 did not. To determine the phosphorylation state of pRB in vitro and in vivo, we raised the specific antibody against phospho-Ser780 in pRB. We confirmed that cyclin D1-Cdk4, but not cyclin E-Cdk2, phosphorylated Ser780 in recombinant pRB. The Ser780 in pRB was phosphorylated in the G1 phase in a cell cycle-dependent manner. Furthermore, we found that pRB phosphorylated at Ser780 cannot bind to E2F-1 in vivo. Our data show that cyclin D1-Cdk4 and cyclin A/E Cdk2 phosphorylate different sites of pRB in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9003781      PMCID: PMC452531     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

1.  The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit.

Authors:  T Durfee; K Becherer; P L Chen; S H Yeh; Y Yang; A E Kilburn; W H Lee; S J Elledge
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

2.  Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.

Authors:  L Zhu; S van den Heuvel; K Helin; A Fattaey; M Ewen; D Livingston; N Dyson; E Harlow
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

3.  A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression.

Authors:  M Kitagawa; H Higashi; I S Takahashi; T Okabe; H Ogino; Y Taya; S Hishimura; A Okuyama
Journal:  Oncogene       Date:  1994-09       Impact factor: 9.867

4.  Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H.

Authors:  H Higashi; I Suzuki-Takahashi; S Saitoh; K Segawa; Y Taya; A Okuyama; S Nishimura; M Kitagawa
Journal:  Eur J Biochem       Date:  1996-04-15

5.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

Authors:  P W Hinds; S Mittnacht; V Dulic; A Arnold; S I Reed; R A Weinberg
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

6.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

Authors:  D E Quelle; R A Ashmun; S A Shurtleff; J Y Kato; D Bar-Sagi; M F Roussel; C J Sherr
Journal:  Genes Dev       Date:  1993-08       Impact factor: 11.361

7.  Phosphorylation of E2F-1 by cyclin A-cdk2.

Authors:  M Kitagawa; H Higashi; I Suzuki-Takahashi; K Segawa; S K Hanks; Y Taya; S Nishimura; A Okuyama
Journal:  Oncogene       Date:  1995-01-19       Impact factor: 9.867

8.  Growth suppression by p16ink4 requires functional retinoblastoma protein.

Authors:  R H Medema; R E Herrera; F Lam; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

9.  Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation.

Authors:  S Mittnacht; J A Lees; D Desai; E Harlow; D O Morgan; R A Weinberg
Journal:  EMBO J       Date:  1994-01-01       Impact factor: 11.598

10.  The retinoblastoma protein is phosphorylated on multiple sites by human cdc2.

Authors:  J A Lees; K J Buchkovich; D R Marshak; C W Anderson; E Harlow
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  208 in total

Review 1.  Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.

Authors:  R J Michalides
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

2.  Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks.

Authors:  K Nakagawa; Y Taya; K Tamai; M Yamaizumi
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

3.  Cumulative effect of phosphorylation of pRB on regulation of E2F activity.

Authors:  V D Brown; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

4.  Reconstitution of cyclin D1-associated kinase activity drives terminally differentiated cells into the cell cycle.

Authors:  L Latella; A Sacco; D Pajalunga; M Tiainen; D Macera; M D'Angelo; A Felici; A Sacchi; M Crescenzi
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 5.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

6.  Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition.

Authors:  D G Pestov; Z Strezoska; L F Lau
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

7.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

Authors:  R Sears; F Nuckolls; E Haura; Y Taya; K Tamai; J R Nevins
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

8.  Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation.

Authors:  Marcelo L Rodriguez-Puebla; Paula L Miliani de Marval; Margaret LaCava; David S Moons; Hiroaki Kiyokawa; Claudio J Conti
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

9.  The structure of CDK4/cyclin D3 has implications for models of CDK activation.

Authors:  T Takaki; A Echalier; N R Brown; T Hunt; J A Endicott; M E M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

10.  In vivo proliferation of differentiated pancreatic islet beta cells in transgenic mice expressing mutated cyclin-dependent kinase 4.

Authors:  S Hino; T Yamaoka; Y Yamashita; T Yamada; J Hata; M Itakura
Journal:  Diabetologia       Date:  2004-10-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.